Prestige Pulls Trastuzumab After EMA Knockback

Formal Withdrawal Of MAA Follows CHMP Negative Opinion And Re-Examination

 
• By David Wallace
  
Withdrawal wooden blocks letters
Prestige has withdrawn its HD201 trastuzumab candidate in Europe • Source: Shutterstock

More from Biosimilars

More from Products